7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      cash flows from operating activities
    		                   
      net income
    		11,879,000 13,855,000 -282,000 7,818,000 -267,000 11,802,000 4,774,000 16,582,000 -9,828,000 18,924,000 16,983,000 118,302,000 12,759,000 7,303,000 4,649,000 -2,152,000 5,276,000 9,154,000 -8,334,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                   
      depreciation and amortization
    		3,362,000 3,335,000 3,287,000 3,294,000 3,151,000 3,179,000 3,002,000 2,785,000 2,652,000 2,585,000 2,507,000 2,508,000 2,599,000 2,708,000 2,694,000 2,708,000 2,537,000 2,407,000 2,401,000 
      amortization/write off of deferred financing costs
    		156,000 155,000 156,000 156,000 156,000 155,000 2,626,000 1,133,000 340,000 342,000 350,000 342,000 339,000 408,000 276,000 277,000 277,000 305,000 5,110,000 
      gain on sale of asset
    		7,000                   
      equity-based compensation
    		2,419,000 2,594,000 2,661,000 3,838,000 1,282,000 4,087,000 5,023,000 3,802,000 5,092,000 4,445,000 7,523,000 4,221,000 3,991,000 4,065,000 3,831,000 4,882,000 2,232,000 2,780,000 1,392,000 
      benefit from obsolete or slow-moving inventory
    		473,000 365,000 252,000 1,165,000 1,039,000   1,402,000 499,000 818,000 2,322,000 1,630,000 0       
      benefit from warranty expense
    		0 -1,000 257,000 0 13,809,000 829,000 565,000 -167,000 50,337,000           
      deferred taxes
    		3,982,000 4,304,000 2,288,000 5,851,000 1,665,000 4,024,000 2,495,000 8,878,000 -6,497,000 5,954,000 2,999,000 3,107,000 2,452,000 1,428,000 1,419,000 -2,116,000 1,164,000 -1,081,000 557,000 
      changes in assets and liabilities:
    		                   
      accounts receivable
    		-14,032,000 -35,728,000 10,477,000 17,120,000 -3,040,000 11,142,000 3,715,000 1,768,000 -11,787,000 -21,672,000 -25,148,000 20,877,000 -13,825,000 -871,000 -25,388,000 13,089,000 3,702,000 -14,839,000 -1,134,000 
      unbilled receivables
    		2,156,000 548,000 10,425,000 -7,042,000 3,223,000 6,391,000 16,730,000 -11,630,000 -6,842,000 -2,003,000 -2,948,000 -5,152,000 3,019,000 1,569,000 -2,616,000 -2,979,000 -3,757,000 3,198,000 -6,201,000 
      inventory
    		-3,924,000 3,909,000 -5,448,000 8,712,000 -6,887,000 -907,000 -6,761,000 6,755,000 6,852,000 4,599,000 -3,197,000 6,674,000 -16,197,000 -16,293,000 -11,111,000 -8,683,000 -2,354,000 -180,000 -5,971,000 
      other assets
    		4,914,000 -978,000 -1,471,000 -7,099,000 -1,877,000 2,374,000 -3,165,000 2,547,000 872,000 1,217,000 -3,281,000 625,000 1,678,000 1,362,000 -3,421,000 7,245,000 -2,273,000   
      accounts payable
    		6,467,000 -583,000 6,682,000 -3,711,000 7,556,000 459,000 1,332,000 -2,219,000 376,000 -5,507,000 12,521,000 -12,215,000 -2,874,000 6,166,000 -2,106,000 1,321,000 -4,788,000 1,283,000 -1,693,000 
      accrued expenses and other
    		7,724,000 4,284,000 -347,000 -540,000 2,967,000 -272,000 -13,402,000 1,141,000 3,550,000 997,000 -1,217,000 -23,888,000 17,816,000       
      warranty liability
    		-12,190,000 -11,626,000 -9,837,000 -13,749,000 -6,396,000 -5,298,000 -3,680,000 -1,533,000            
      deferred revenue
    		6,024,000 4,880,000 -3,542,000 -1,825,000 -682,000 -590,000 -394,000 -4,797,000 -4,273,000 7,848,000 191,000         
      net cash from operating activities
    		19,417,000 -13,821,000 15,558,000 13,988,000 15,699,000 37,841,000 12,860,000 26,447,000 27,674,000 27,921,000 9,913,000 34,441,000 11,757,000 19,116,000 -25,859,000 2,596,000 7,435,000 3,665,000 -17,779,000 
      capex
    		-10,449,000 -12,221,000 -3,209,000 -1,531,000 -2,377,000 -2,002,000 -2,483,000 -2,936,000 -3,265,000 -2,374,000 -2,003,000 -761,000 -244,000 -1,267,000 -882,000 -1,643,000 -747,000 -873,000 -863,000 
      free cash flows
    		8,968,000 -26,042,000 12,349,000 12,457,000 13,322,000 35,839,000 10,377,000 23,511,000 24,409,000 25,547,000 7,910,000 33,680,000 11,513,000 17,849,000 -26,741,000 953,000 6,688,000 2,792,000 -18,642,000 
      cash flows from investing activities
    		                   
      purchases of property, plant and equipment
    		-10,449,000 -12,221,000 -3,209,000 -1,531,000 -2,377,000 -2,002,000 -2,483,000 -2,936,000 -3,265,000 -2,374,000 -2,003,000 -761,000 -244,000 -1,267,000 -882,000 -1,643,000 -747,000 -873,000 -863,000 
      proceeds from sale of property, plant and equipment
    		0                   
      net cash from investing activities
    		-10,449,000 -7,133,000 -3,209,000 -1,531,000 -2,377,000 -2,002,000 -2,483,000 -2,936,000 -3,534,000 -2,374,000 -2,003,000 -761,000 -747,000 -1,267,000 -882,000 -1,643,000 -13,656,000 -873,000 -863,000 
      cash flows from financing activities
    		                   
      employee withholding taxes related to net settled equity awards
    		-65,000 -28,000 -251,000 -52,000 -305,000 -49,000 -816,000 -28,000 -276,000 -44,000 -3,532,000 0 0 0 -1,297,000 0 0 0 -137,000 
      payments on term loan facility
    		   0 0 0 -143,750,000 -50,000,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000   
      proceeds from revolving credit facility
    		20,000,000 10,000,000 20,000,000 0 0 5,000,000 143,750,000 40,000,000 0 0 5,000,000 0 8,000,000 3,000,000 35,000,000 9,000,000 6,140,000 15,000,000 19,000,000 
      repayments of revolving credit facility
    		-25,000,000 -20,000,000 -20,000,000 0 -5,000,000 -27,000,000 -15,000,000 0 -20,000,000 -25,000,000 -8,000,000 -37,640,000 -7,500,000       
      deferred financing costs
    		   0 0 -606,000 -2,032,000         0 0 0 -94,000 
      repurchase of class a common stock
    		   0 -100,000               
      excise taxes on treasury stock transactions
    		0                   
      net cash from financing activities
    		-5,065,000 -9,969,000 -251,000 -52,000 -5,405,000 -47,886,000 -17,848,000 -10,028,000 -20,776,000 -26,147,000 -10,216,000 -56,530,000 -3,196,000 -7,128,000 30,265,000 -5,585,000 7,239,000 6,152,000 12,796,000 
      net decrease in cash and cash equivalents
    		3,903,000     -12,047,000 -7,471,000             
      cash and cash equivalents—beginning of period
    		0 0 23,511,000  0 0 22,707,000           0 10,073,000 
      cash and cash equivalents—end of period
    		3,903,000 -30,923,000 35,609,000  7,917,000 -12,047,000 15,236,000           8,944,000 4,227,000 
      net increase in cash and cash equivalents
    		  12,098,000              1,018,000 8,944,000 -5,846,000 
      benefit from credit losses
    		       0 0 -12,000 308,000         
      payable pursuant to the tax receivable agreement adjustment
    		                   
      gain on termination of tax receivable agreement
    		                   
      other
    		       0 890,000 -603,000 -556,000 0        
      distributions to non-controlling interests
    		       0 0 0 -2,628,000         
      proceeds from issuance of class a common stock in follow-on offering, net of underwriting discounts and commissions
    		               0    
      deferred offering costs
    		               -85,000 0 0 -9,619,000 
      early termination payment of tax receivable agreement
    		                   
      payment of fees for tax receivable agreement termination
    		                   
      net increase in cash, cash equivalents
    		                   
      cash, cash equivalents—beginning of period
    		                   
      cash, cash equivalents—end of period
    		                   
      gain on sale of assets
    		               -9,000 0 0 61,000 
      changes in assets and liabilities, net of business acquisition:
    		                   
      acquisition of a business, net of cash acquired
    		               0    
      proceeds from issuance of class a common stock sold in an ipo, net of underwriting discounts and commissions
    		                0 0 154,521,000 
      purchase of llc interests with proceeds from ipo
    		                   
      purchase of llc interests with proceeds from follow-on offering
    		               0    
      payment of debt assumed in acquisition
    		                   
      net increase in cash, cash equivalents and restricted cash
    		       13,483,000 3,364,000 -600,000 -2,306,000 -22,850,000 7,814,000 10,721,000 3,524,000     
      cash, cash equivalents and restricted cash—beginning of period
    		       0 0 0 8,766,000   0 9,557,000     
      cash, cash equivalents and restricted cash—end of period
    		       13,483,000 3,364,000 -600,000 6,460,000   10,721,000 13,081,000     
      cash flows used in investing activities
    		                   
      proceeds from term loan facility
    		                   
      payments on senior debt - term loan
    		                   
      proceeds from delayed draw term loan facility
    		                   
      payments on delayed draw term loan facility
    		                   
      distributions to non-controlling interest
    		            -3,196,000 -1,628,000 -2,938,000     
      accrued expenses
    		              5,914,000 -7,119,000 2,970,000 140,000 -502,000 
      benefit from slow-moving inventory
    		               -1,853,000    
      payable pursuant to the tra adjustment
    		                   
      member / non-controlling interest distributions
    		               0 -1,864,000   
      proceeds from issuance of class a common stock sold in an ipo
    		                   
      proceeds from senior debt - revolving line of credit
    		                   
      payments on senior debt - revolving line of credit
    		                   
      tax receivable agreement liability adjustment
    		                2,014,000   
      payment of debt acquired in acquisition
    		                   
      other current assets
    		                  -3,465,000 
      member distributions
    		                   
      payment on term loan facility
    		                  -150,875,000 
      amortization of deferred finance costs
    		                   
      debt discount and financing costs
    		                   
      repayment of related party note payable
    		                   
      cash and cash equivalents—beginning of year
    		                   
      cash and cash equivalents—end of year
    		                   
      supplemental cash flows information:
    		                   
      cash paid for interest
    		                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.